110 related articles for article (PubMed ID: 2141296)
1. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas.
Sturm SA; Strauss PG; Adolph S; Hameister H; Erfle V
Cancer Res; 1990 Jul; 50(13):4146-53. PubMed ID: 2141296
[TBL] [Abstract][Full Text] [Related]
2. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
3. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
[TBL] [Abstract][Full Text] [Related]
5. Provirus integration and myc amplification in 90Sr induced osteosarcomas of CF1 mice.
Van der Rauwelaert E; Maisin JR; Merregaert J
Oncogene; 1988 Mar; 2(3):215-22. PubMed ID: 2832803
[TBL] [Abstract][Full Text] [Related]
6. Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas.
Palumbo AP; Boccadoro M; Battaglio S; Corradini P; Tsichlis PN; Huebner K; Pileri A; Croce CM
Cancer Res; 1990 Oct; 50(20):6478-82. PubMed ID: 2208106
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
[TBL] [Abstract][Full Text] [Related]
8. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
[TBL] [Abstract][Full Text] [Related]
10. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
11. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
[TBL] [Abstract][Full Text] [Related]
12. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
[TBL] [Abstract][Full Text] [Related]
13. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
Colledge WH; Gebhardt A; Edge MD; Bell JC
Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
[TBL] [Abstract][Full Text] [Related]
14. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor.
Yander G; Halsey H; Kenna M; Augenlicht LH
Cancer Res; 1985 Sep; 45(9):4433-8. PubMed ID: 4028026
[TBL] [Abstract][Full Text] [Related]
15. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
17. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
Maillet MW; Robinson RA; Burgart LJ
Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]